The true incidence and prevalence of dilated cardiomyopathy are unknown and likely to remain unknown for some time to come. There are several reasons for this state of affairs, which also apply to several other disease syndromes ofunknown or uncertain aetiology, the definition, recognition and understanding of which are in a state of change.
(1) The clinical diagnosis is unreliable (Abelmann, 1984) . Dilated cardiomyopathy is generally underdiagnosed, especially in the earlier, asymptomatic stages. Inasmuch as the incidence is greater in males, and especially in mature males (see below), it is often misdiagnosed as ischaemic heart disease (especially in developed countries), sometimes as valvular heart disease, and, in certain countries of South America, as Chagas' disease. (2) Autopsies are performed only occasionally.
Autopsies are carried out in only a small fraction of deaths from heart disease, and, at least in the United States, only on a fraction ofsudden deaths. (3) Samples of the population are usually biased.
Clinical as well as post-mortem series are usually reported from centres with special interest, especially high incidence, or both. (Fejfar, 1968) . (5) Apparent changes in incidence and prevalence of cardiomyopathy must be interpreted with caution. In recent years, the incidence of cardiomyopathy appears to have increased. While this impression is difficult to refute, changing frequencies of encounters are more likely to be a function of the tremendous increase in the sensitivity of non-invasive and invasive methods of detection of impaired myocardial function, the expansion of the number of physicians trained in diagnostic cardiology, and changing patient-referral patterns. With these caveats in mind, let us examine some of the available data.
Mortality from cardiomyopathy
In 1979, deaths from all disease of the circulatory system in the United States numbered 963,037. There, were 6,912 reported deaths from cardiomyopathy, or 0.71% of all cardiovascular deaths (Vital Statistics of the U.S., 1979). This should be accepted as a minimal number, probably a significant underestimate. The ) 
Prevalence of cardiomyopathy in hospitals and physicians' offices
The US Hospital Discharge Survey in 1979 provides data which represent extrapolation from some 400 monitored institutions to the country as a whole. Of 18,346,000 patients diagnosed as having diseases of the circulatory system, 126,000 or 0.67% had cardiomyopathy. The respective figures for the primary diagnosis were 5,488,000 and 46,000 (0.84%). A similar prevalence was found by a survey of US cardiology manpower in 1973 (Swan & Gifford, 1974) : cardiomyopathy accounted for 1% of all cardiologists' patient encounters. In academic cardiologists' practices, however, the prevalence was 7%.
Incidence of cardiomyopathy in population surveys Torp (1978 Torp ( , 1981 surveyed the incidence ofcongestive (dilated) cardiomyopathy in the city of Malmo, Sweden, which has a relatively stable population of 250,000 and is served by only one hospital with an autopsy rate of 90%. Over the 10 year period of this prospective study, from 1970 to 1979, 89 cases of dilated cardiomyopathy were diagnosed clinically, and an additional 56 cases at post-mortem examination, using the current WHO/ISFC classification (1980). Thus there was an incidence of 7.5 cases of dilated cardiomyopathy per 100,000 inhabitants per year. It is of interest that another, albeit retrospective, Scandinavian study (Bagger et al., 1984 ) yielded a significantly lower annual incidence of 0.73 cases of dilated cardiomyopathy per 100,000 population in 1980/1, based upon a population of 2,798,000 in Western Denmark. The authors considered this figure to be a minimum, and gave several reasons for this being an underestimate, including rigid criteria, short period of observation, low autopsy rate and incomplete referrals.
A survey by questionnaire in 1974 revealed a minimum annual incidence of 2.6 cases of cardiomyopathy (all types) per 100,000 population in Tokyo (Kawai, 1978) , of which, however, only about 38% had dilated cardiomyopathy (Kawai, 1980) . In contrast, in the United States, dilated cardiomyopathy comprises about 90% of all cardiomyopathies.
It is noteworthy that the above data were all obtained in developed countries. It is generally agreed that in many underdeveloped countries, especially in the tropics, dilated cardiomyopathy, including specific heart muscle diseases such as Chagas' disease (Correa et al., 1963) and myocarditis, are considerably more frequent than in developed countries, ranging from 3% of cardiac diagnoses at autopsy in Cali, Colombia (Correa et al., 1963) , to 45% of all autopsies in Bahia, Brazil (K6berle, 1957 
